Comparison of the tumor immune microenvironment phenotypes in different breast cancers after neoadjuvant therapy

Comparison of the tumor immune microenvironment phenotypes in different breast cancers after neoadjuvant therapy

Abstract Neoadjuvant therapy (NAT) treats early‐stage breast cancers, especially triple‐negative breast cancers (TNBCs). NAT improves pathological complete response (pCR) rates for different breast cancer patients. Recently, immune checkpoint inhibitors that target programmed death 1 (PD‐1) or progr...

Full description

Saved in:
Bibliographic Details
Main Authors: Mengxue Han, Jinze Li, Si Wu, Chun Wu, Yongqiang Yu, Yueping Liu
Format: Article
Language:English
Published: Wiley 2023-02-01
Series:Cancer Medicine
Subjects:
immune microenvironment
neoadjuvant therapy
PD‐L1
triple‐negative breast cancer
tumor‐infiltrating lymphocytes
Online Access:https://doi.org/10.1002/cam4.5207
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

https://doi.org/10.1002/cam4.5207

Similar Items